GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
2.800
-0.030 (-1.06%)
At close: Jan 30, 2026, 4:00 PM EST
2.880
+0.080 (2.86%)
After-hours: Jan 30, 2026, 7:52 PM EST
GeoVax Labs Market Cap
GeoVax Labs has a market cap or net worth of $4.81 million as of January 30, 2026. Its market cap has decreased by -77.34% in one year.
Market Cap
4.81M
Enterprise Value
-198.57K
1-Year Change
-77.34%
Ranking
Category
Stock Price
$2.80
Market Cap Chart
Since September 11, 2019, GeoVax Labs's market cap has increased from $239.88K to $4.81M, an increase of 1,905.35%. That is a compound annual growth rate of 59.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 4.81M | -34.50% |
| Dec 31, 2025 | 7.34M | -68.49% |
| Dec 31, 2024 | 23.31M | 141.85% |
| Dec 29, 2023 | 9.64M | -41.93% |
| Dec 30, 2022 | 16.60M | -28.16% |
| Dec 31, 2021 | 23.10M | 92.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genprex | 5.70M |
| Xenetic Biosciences | 5.34M |
| Abpro Holdings | 5.30M |
| Decoy Therapeutics | 5.29M |
| Cyclerion Therapeutics | 5.21M |
| Indaptus Therapeutics | 4.91M |
| Moolec Science | 4.70M |
| Psyence Biomedical | 4.60M |